» Articles » PMID: 37770941

The Critical Role of Platelet in Cancer Progression and Metastasis

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2023 Sep 28
PMID 37770941
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets play a crucial role in cancer blood metastasis. Various cancer-related factors such as Toll-like receptors (TLRs), adenosine diphosphate (ADP) or extracellular matrix (ECM) can activate these small particles that function in hemostasis and thrombosis. Moreover, platelets induce Epithelial Mesenchymal Transition (EMT) to promote cancer progression and invasiveness. The activated platelets protect circulating tumor cells from immune surveillance and anoikis. They also mediate tumor cell arrest, extravasation and angiogenesis in distant organs through direct or indirect modulation, creating a metastatic microenvironment. This review summarizes the recent advances and progress of mechanisms in platelet activation and its interaction with cancer cells in metastasis.

Citing Articles

Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer.

Hirakawa T, Yamaguchi K, Funaishi K, Shimoji K, Sakamoto S, Horimasu Y Cancers (Basel). 2025; 17(4).

PMID: 40002167 PMC: 11853576. DOI: 10.3390/cancers17040572.


PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer.

Li J, Liu J, Yang S, Xia Y, Meng Q, Sun B Cell Commun Signal. 2025; 23(1):29.

PMID: 39815258 PMC: 11737274. DOI: 10.1186/s12964-025-02034-0.


Predicting the risk of pulmonary embolism in patients with tuberculosis using machine learning algorithms.

Kong H, Li Y, Shen Y, Pan J, Liang M, Geng Z Eur J Med Res. 2024; 29(1):618.

PMID: 39710777 PMC: 11664847. DOI: 10.1186/s40001-024-02218-3.


A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma.

Wei S, Zhou J, Dong B Hereditas. 2024; 161(1):52.

PMID: 39707577 PMC: 11662788. DOI: 10.1186/s41065-024-00355-7.


Real‑world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer.

Qian X, Tao Y, Chen H, Li X, Wang Y, Xu X Oncol Lett. 2024; 29(1):29.

PMID: 39512498 PMC: 11542155. DOI: 10.3892/ol.2024.14775.


References
1.
Selvadurai M, Hamilton J . Structure and function of the open canalicular system - the platelet's specialized internal membrane network. Platelets. 2018; 29(4):319-325. DOI: 10.1080/09537104.2018.1431388. View

2.
Cavanaugh P, Sloane B, Honn K . Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. Haemostasis. 1988; 18(1):37-46. DOI: 10.1159/000215781. View

3.
Tsubakihara Y, Moustakas A . Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β. Int J Mol Sci. 2018; 19(11). PMC: 6274739. DOI: 10.3390/ijms19113672. View

4.
Carpinteiro A, Becker K, Japtok L, Hessler G, Keitsch S, Pozgajova M . Regulation of hematogenous tumor metastasis by acid sphingomyelinase. EMBO Mol Med. 2015; 7(6):714-34. PMC: 4459814. DOI: 10.15252/emmm.201404571. View

5.
Haemmerle M, Stone R, Menter D, Afshar-Kharghan V, Sood A . The Platelet Lifeline to Cancer: Challenges and Opportunities. Cancer Cell. 2018; 33(6):965-983. PMC: 5997503. DOI: 10.1016/j.ccell.2018.03.002. View